Supplements for Dry Eyes: What the Trials Actually Show

Dry eyes are rarely one problem. In some people the watery layer of the tear film is not being made well enough. In others the oil layer fails, so tears evaporate almost as fast as they form. Many people have both at once. The supplement shelf does not sort itself that way. Most supplements for dry eyes promise "eye support," and almost none tell you which problem the ingredients are meant to help with. This guide sorts them, nutrient by nutrient, at the doses studied, including the result that confuses everyone. One of the largest and most rigorous omega-3 trials for dry eyes came back negative.

The Two Things That Actually Go Wrong

Your tears are not just water. They are a thin film, and two outer layers do most of the work.

• The watery (aqueous) layer keeps the eye moist and washes away debris.
• The oil (lipid) layer floats on top and slows evaporation. It comes from tiny glands in your eyelids called meibomian glands.

When the watery layer runs short, doctors call it aqueous-deficient dry eye. When the oil layer fails, tears evaporate too quickly, a pattern tied to meibomian gland dysfunction, or MGD.

Which layer is failing decides what is likely to help you. A nutrient aimed at tear production does little for a clogged oil gland, and the reverse is just as true.

Symptoms alone will not tell them apart. Tests such as tear break-up time, the Schirmer test, and gland expression are how an eye doctor sorts it out, and if you have never had that done, that appointment is worth more than any bottle.

Why "Does Fish Oil Work for Dry Eyes?" Has No Single Answer

Search omega-3 for dry eyes and you find two confident camps: one says it works, the other says the evidence is mixed. Both quote real studies, which is why the answer feels slippery.

Omega-3 is not one thing. Dose, the EPA to DHA ratio, the form, duration, and your starting omega-3 status all change what it does. Two trials can use the words "fish oil," land in opposite places, and both be right.

The DREAM Trial: The Big One Came Back Negative

The DREAM trial randomized 349 people to a daily fish-derived supplement of 3,000 mg EPA and DHA, and 186 to an olive oil placebo, for 12 months.

The result was null. OSDI symptom scores fell 13.9 points on omega-3 and 12.5 points on placebo. The difference, 1.9 points, was not statistically significant (P=0.21), and people taking olive oil improved almost as much as people taking 3,000 mg of fish oil. Tear break-up time, the Schirmer test, and corneal and conjunctival staining showed no significant difference either. Adherence was strong at 85.2%, so this was not people forgetting their capsules, and the study was funded by the National Eye Institute.

A follow-up study found that when participants stopped the omega-3, their eyes did not get worse.

The Second Null: The 2024 Re-Esterified Triglyceride Trial

The next guess is that DREAM used the wrong form. So a 2024 JAMA Ophthalmology trial tested the premium one: re-esterified triglyceride omega-3, at 1,680 mg EPA plus 560 mg DHA, in 132 people with dry eye and meibomian gland dysfunction, over 12 weeks.

It was null too. OSDI fell 22.7 points on omega-3 against 18.8 on a grape-seed oil control, a difference of 3.9 points that did not reach significance (P=0.28).

The control group improved by roughly 19 points. Whatever is happening in these trials, a large part of it is not the fish oil.

How to Reconcile the Negative Trials With the Positive Pooled Data

But when researchers pool many trials together, a signal appears.

The Pooled Evidence: 19 Trials, 4,246 Patients

A 2023 meta-analysis combined 19 randomized trials covering 4,246 people. It found significant improvements versus placebo in symptoms, tear break-up time, the Schirmer test, corneal staining, and tear osmolarity.

More useful is what predicted a better response. Higher daily dose (P=0.002), longer duration (P=0.021), and a higher EPA percentage (P<0.001) each tracked with greater symptom relief, though the authors urge caution because the studies differ.

Who Actually Responds: The Omega-3 Index

A second clue comes from a 2023 trial in 470 people who use computers all day, against 480 on an olive oil placebo, over six months. The dose was 1,440 mg EPA and 960 mg DHA daily.

At the start, 81% of participants had a low omega-3 index. Those who improved most started lowest, in the group under 4%. Improvement was significantly greater in that low-index subgroup (P<0.001), and none of the benefits appeared on placebo.

Put the pieces together and the question changes shape. It is not "does omega-3 work for dry eyes." It is a dose, an EPA ratio, and a baseline-status question. Someone already replete may see nothing. Someone who starts low, takes a higher-EPA dose, and stays with it for months is a different case entirely. If you want to run that version of the experiment for yourself, the Nordic Naturals ProOmega 2000-D is a concentrated omega-3 that prints its EPA and DHA per serving on the label.

Why Symptoms and Signs Do Not Move Together

Dry eye research measures two different things, and knowing which is which can save you money.

• Signs are what a clinician measures: tear break-up time, the Schirmer test, staining, osmolarity.
• Symptoms are what you report: the OSDI questionnaire and similar scales.

The two do not always agree.

• An earlier meta-analysis of 7 studies and 790 people found tear break-up time better by 1.58 seconds and Schirmer scores improved, while symptom scores did not improve significantly.
• The 2023 pooled analysis found improvements in both.
• The 2025 lutein and zeaxanthin trial in screen users found measured signs improving while self-reported symptoms did not.
• DREAM found the opposite mismatch: symptoms improved in both arms with no separation.

A test can improve while you feel the same, and you can feel better while a test does not move. So give a supplement months before you judge it, and repeat the same measurement at the start and the end.

Lutein and Zeaxanthin for Dry Eyes

Lutein and zeaxanthin are the two carotenoids your eye concentrates in the macula, and they are commonly sold alongside omega-3. Two trials are worth knowing. A dedicated eye formula such as XYMOGEN I-Sight is the common way to take them together with other ocular antioxidants.

A 20-Day Trial With a Big Symptom Drop

A 2024 trial in 110 people tested 6 mg lutein plus 1 mg zeaxanthin plus 100 mg elderberry extract, once daily for 20 days. OSDI fell from 38.15 to 18.26, a 52.2% reduction.

Two caveats. The immune measure in the same study did not beat placebo, and the first author was employed by a supplement manufacturer, a conflict of interest worth weighing. Read this one as supportive, not definitive.

A 6-Month Trial in Heavy Screen Users

A 2025 trial followed 70 people who use screens more than six hours a day, giving them 10 mg lutein plus 2 mg zeaxanthin isomers for six months. Measured signs improved versus placebo: the Schirmer test, photo-stress recovery time, and tear film break-up time. Self-reported symptoms did not differ between groups, the signs-versus-symptoms split again.

Most People Eat Very Little of These Two

In the 2024 trial, a food questionnaire put average lutein and zeaxanthin intake at 663.49 mcg per day, roughly 5.5% of the suggested optimal intake. If your diet is light on leafy greens and colorful vegetables, your intake is likely low too. For how carotenoids fit the wider picture, see our brain and memory resources.

Vitamin D and Dry Eyes

The key source here is a 2023 review, not a trial. It reasons that vitamin D may support the tear film and the body's normal inflammatory response, and suggests it as a plausible add-on, especially for people whose dry eye does not respond to the usual approaches. That is a reasonable hypothesis. It is not proof, and a review is the weakest form of evidence worth acting on.

So how should you read searches about a dry eye vitamin deficiency? Low vitamin D has been associated with eye-surface complaints, but association is not cause. If you are concerned, the sensible step is a blood test through your doctor, not a guess.

Can Too Much Vitamin D Cause Dry Eyes?

No credible source in the research behind this guide links vitamin D to causing dry eye. The real concern runs the other way: too much can be toxic. For most adults, higher doses of vitamin D belong under medical supervision. Very high intakes over time can raise blood calcium, which is genuinely dangerous.

Vitamin B12 and the Deficiency Question

B12 is a different story. Here the issue is straightforward deficiency, and it shows up in the eye as nerve pain rather than as dryness alone.

A 2017 study followed 90 people with severe dry eye and ocular pain. The 45 with a low B12 level had more neuropathic ocular pain, and the authors concluded that measuring serum B12 in these patients matters. One honest caveat: correcting the deficiency did not outperform topical treatment alone, so B12 reads as a factor to check rather than a stand-alone answer.

A second trial points the same direction. A 2022 double-blind randomized trial gave 199 people oral vitamin B1 plus mecobalamin alongside artificial tears, and found greater improvement than artificial tears alone in corneal fluorescein staining (p=0.012), photophobia (p=0.032), total symptom score (p=0.041), and OSDI (p=0.029) at three months.

The sensible move is to test before you supplement. A blood test tells you whether you are actually low. If it confirms you are low, correcting it is your doctor's call. This guide will not invent a consumer B12 dose, because the trials above tested clinical protocols rather than an off-the-shelf regimen.

The Gut-Eye Axis: Early, Small, and Interesting

The gut-eye connection is one of the newer angles in eye research, and it is early and small.

A 2022 double-masked randomized trial gave a probiotic and prebiotic combination to 41 people for four months. Final OSDI was 16.8 in the treatment group against 23.4 in controls, a significant difference. Two measured signs, non-invasive break-up time and tear meniscus height, did not change significantly with treatment, though they worsened in controls.

That is a real result in a tiny group. Treat it as a promising lead, not a recommendation. The general case for supporting digestion is stronger than the specific case for eye symptoms. Our digestion and gastrointestinal support collection is the place to start.

What Does Not Have Good Evidence, and What to Be Careful With

Most pages on vitamins for dry eyes tell you what to take. Here is what to skip.

Nutrients You Can Have Too Much Of

More is not safer.

• Vitamin E. A meta-analysis of 19 trials and 135,967 people concluded that high doses, 400 IU per day or more, should be avoided.
• Vitamin A. High doses carry real risk. In pregnancy, over 10,000 IU per day is a concern, and roughly 50,000 IU taken acutely is dangerous.
• Zinc. Excess zinc impairs copper absorption, so a high-zinc product can quietly create a copper problem.
• Omega-3. Above about 2,000 mg per day, omega-3 has been linked to a slight increase in bleeding risk. Below that line, the most common side effect is stomach upset. People with atrial fibrillation, liver disease, or a bleeding disorder are advised against it.

Interactions to Respect

• Ginkgo biloba should be avoided by anyone at bleeding risk or taking an anticoagulant.
• Coenzyme Q10 can reduce the response to warfarin and may interfere with certain chemotherapy drugs.

Things This Guide Cannot Grade

Astaxanthin for dry eyes is a popular label ingredient. The reference set behind this guide did not include a human trial strong enough to rank it, so it is left ungraded rather than promoted on hype. The same caution applies to collagen, and the same review notes that green tea may compromise tear quality in some people.

How to Actually Choose a Supplement

You need one or two well-chosen products, matched to your problem.

1. Match the nutrient to the layer that is failing. Tear production and meibomian gland dysfunction point to different nutrients. If the antioxidant side is where you want to start, Pure Encapsulations EyeProtect Basics is a simple vitamin C, vitamin E, and zinc blend.
2. Read the EPA and DHA numbers, not the total fish oil weight. A bottle that says "1,000 mg fish oil" may contain only a few hundred milligrams of what matters. The number that counts is the combined EPA plus DHA per serving, and the EPA share relative to DHA.
3. Check the form and the freshness. Omega-3 oils oxidize. If a capsule smells strongly rancid, treat that as a sign it has turned.
4. Look for third-party testing. Independent testing for purity and potency is a reasonable quality signal, and Agape's specialty support range is chosen with that bar in mind.
5. Consider testing your omega-3 index. Since a low starting index predicted benefit in the research, knowing your number turns a guess into a decision.
6. Give it enough time. The trials that found benefit ran for months. Two weeks tells you almost nothing.
7. Tell your doctor and your pharmacist, especially if you take a blood thinner or face surgery.

For the wider context on these nutrients and the body's normal inflammatory response, our heart and circulation resources are a useful companion read.

And one line that matters most: none of this is a reason to stop a treatment your eye doctor prescribed. A supplement sits alongside prescription drops and in-office procedures, never in place of them.

References

1. Dry Eye Assessment and Management Study Research Group; Asbell PA, Maguire MG, Pistilli M, et al. "n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease." N Engl J Med, 2018. https://pubmed.ncbi.nlm.nih.gov/29652551/
2. Hussain M, Shtein RM, Pistilli M, Maguire MG, et al. "The Dry Eye Assessment and Management (DREAM) extension study: a randomized clinical trial of withdrawal of supplementation with omega-3 fatty acid in patients with dry eye disease." Ocul Surf, 2020. https://pubmed.ncbi.nlm.nih.gov/31425752/
3. Eom Y, Jun I, Jeon HS, Lim DH, et al. "Re-Esterified Triglyceride omega-3 Fatty Acids in Dry Eye Disease With Meibomian Gland Dysfunction: A Randomized Clinical Trial." JAMA Ophthalmol, 2024. https://pubmed.ncbi.nlm.nih.gov/38753336/
4. Bhargava R, Pandey K, Ranjan S, Mehta B, Malik A. "Omega-3 fatty acids supplements for dry eye: Are they effective or ineffective?" Indian J Ophthalmol, 2023. https://pubmed.ncbi.nlm.nih.gov/37026312/
5. Wang WX, Ko ML. "Efficacy of Omega-3 Intake in Managing Dry Eye Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials." J Clin Med, 2023. https://pubmed.ncbi.nlm.nih.gov/38002640/
6. Liu A, Ji J. "Omega-3 essential fatty acids therapy for dry eye syndrome: a meta-analysis of randomized controlled studies." Med Sci Monit, 2014. https://pubmed.ncbi.nlm.nih.gov/25193932/
7. Al-Namaeh M. "A systematic review of the effect of omega-3 supplements on meibomian gland dysfunction." Ther Adv Ophthalmol, 2020. https://pubmed.ncbi.nlm.nih.gov/33134837/
8. Goh KM, Tan ESS, Lim CSY, Tan PY, Biswas S, Lew LA, Tan CK. "Effect of Dietary Supplementation with Lutein, Zeaxanthin, and Elderberries on Dry Eye Disease (DED) and Immunity: A Randomized Controlled Trial." Nutrients, 2024. https://pubmed.ncbi.nlm.nih.gov/39770987/
9. Lopresti AL, Smith SJ. "The effects of lutein/zeaxanthin (Lute-gen) on eye health, eye strain, sleep quality, and attention in high electronic screen users: a randomized, double-blind, placebo-controlled study." Front Nutr, 2025. https://pubmed.ncbi.nlm.nih.gov/39963662/
10. Tavakoli A, Markoulli M, Papas E, Flanagan J. "The Impact of Probiotics and Prebiotics on Dry Eye Disease Signs and Symptoms." J Clin Med, 2022. https://pubmed.ncbi.nlm.nih.gov/36013128/
11. Rolando M, Barabino S. "Dry Eye Disease: What Is the Role of Vitamin D?" Int J Mol Sci, 2023. https://pubmed.ncbi.nlm.nih.gov/36674972/
12. Cong Y, Zhang Y, Han Y, Wu Y, Wang D, Zhang B. "Recommendations for nutritional supplements for dry eye disease: current advances." Front Pharmacol, 2024. https://pubmed.ncbi.nlm.nih.gov/38873421/
13. Ozen S, Ozer MA, Akdemir MO. "Vitamin B12 deficiency evaluation and treatment in severe dry eye disease with neuropathic ocular pain." Graefes Arch Clin Exp Ophthalmol, 2017. https://pubmed.ncbi.nlm.nih.gov/28299439/
14. Ren X, Chou Y, Wang Y, Jing D, Chen Y, Li X. "The Utility of Oral Vitamin B1 and Mecobalamin to Improve Corneal Nerves in Dry Eye Disease: An In Vivo Confocal Microscopy Study." Nutrients, 2022. https://pubmed.ncbi.nlm.nih.gov/36145126/

What We Recommend

Every pick below is live and in stock at Agape Nutrition as of this writing. They split along the same line this guide draws, with the omega-3 products differing in concentration and form and the carotenoid products differing in what they add around lutein. Match the pick to the layer of the tear film you and your eye doctor are working on.

Frequently Asked Questions